Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes

被引:15
作者
Cuna, Alain [1 ,2 ,3 ]
Lewis, Tamorah [1 ,2 ,3 ]
Dai, Hongying [4 ]
Nyp, Michael [1 ,2 ,3 ]
Truog, William E. [1 ,2 ,3 ]
机构
[1] Childrens Mercy Kansas City, Div Neonatol, 2401 Gillham Rd, Kansas City, MO 64108 USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Childrens Mercy Kansas City, Ctr Infant Pulm Disorders, Kansas City, MO USA
[4] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
关键词
bronchopulmonary dysplasia; dexamethasone; postnatal corticosteroids; prematurity; preterm; CHRONIC LUNG-DISEASE; BIRTH-WEIGHT INFANTS; RESPIRATORY-DISTRESS-SYNDROME; PLACEBO-CONTROLLED TRIAL; 42-DAY TAPERING COURSE; PRETERM INFANTS; DEXAMETHASONE THERAPY; SYSTEMIC CORTICOSTEROIDS; VENTILATOR DEPENDENCY; CEREBRAL-PALSY;
D O I
10.1002/ppul.24202
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To determine the association of timing of steroid therapy for bronchopulmonary dysplasia (BPD) and outcomes. Methods Retrospective cohort study of preterm infants treated with low-dose dexamethasone for BPD. Infants treated with steroids at day of life (DOL) 14-28 (moderately late group) were compared to infants treated at DOL 29-42 (delayed group). Inverse probability of treatment weighting (IPTW) adjusted propensity scores were used to correct for potential confounders. The primary outcome of interest was postmenstrual age (PMA) at discharge. Results Fifty-five infants (25 with moderately late treatment; 30 with delayed treatment) were identified. The mean age at treatment was 23 days in the moderately late group and 35 days in the delayed group. At time of treatment, infants treated moderately late were more likely to be on high frequency ventilation (96% vs 47%, P < 0.0001) and had higher fraction of inspired oxygen (70.7 +/- 17.9% vs 56.2 +/- 18.4%, P = 0.005) compared to infants treated later. Despite being the sicker group, moderately late treated infants were discharged at an earlier corrected age compared to infants with delayed treatment (PMA 42.9 +/- 4.5 vs 47.5 +/- 8.3 weeks, IPTW adjusted P = 0.03). Moderately late treatment was also associated with fewer days on mechanical ventilation (46.0 +/- 19.0 days vs 77.4 +/- 67.0 days, IPTW adjusted P = 0.02) and fewer days on supplemental oxygen (114.3 +/- 40.8 days vs 149.8 +/- 57.0 days, IPTW adjusted P = 0.005). Conclusions Among preterm infants at high risk of BPD, delaying treatment with postnatal steroids is associated with comparatively worse short-term outcomes as compared to earlier treatment.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 28 条
[1]   Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis [J].
Aldana-Aguirre, Jose C. ;
Pinto, Merlin ;
Featherstone, Robin M. ;
Kumar, Manoj .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2017, 102 (01) :F17-F23
[2]   Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies [J].
Austin, Peter C. ;
Stuart, Elizabeth A. .
STATISTICS IN MEDICINE, 2015, 34 (28) :3661-3679
[3]   Current concepts: Chronic lung disease after premature birth [J].
Baraldi, Eugenio ;
Filippone, Marco .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1946-1955
[4]   The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs [J].
Barrington K.J. .
BMC Pediatrics, 1 (1)
[5]   A CONTROLLED TRIAL OF DEXAMETHASONE IN PRETERM INFANTS AT HIGH-RISK FOR BRONCHOPULMONARY DYSPLASIA [J].
CUMMINGS, JJ ;
DEUGENIO, DB ;
GROSS, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (23) :1505-1510
[6]   A comparison of 7-day versus 10-day course of low-dose dexamethasone for chronically ventilated preterm infants [J].
Cuna, A. ;
Govindarajan, S. ;
Oschman, A. ;
Dai, H. ;
Brophy, K. ;
Norberg, M. ;
Truog, W. .
JOURNAL OF PERINATOLOGY, 2017, 37 (03) :301-305
[7]   Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit? [J].
Doyle, Lex W. ;
Cheong, Jeanie L. Y. .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2017, 22 (05) :290-295
[8]   An Update on the Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk of Bronchopulmonary Dysplasia [J].
Doyle, Lex W. ;
Halliday, Henry L. ;
Ehrenkranz, Richard A. ;
Davis, Peter G. ;
Sinclair, John C. .
JOURNAL OF PEDIATRICS, 2014, 165 (06) :1258-1260
[9]   Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: A multicenter, international, randomized, controlled trial [J].
Doyle, LW ;
Davis, PG ;
Morley, CJ ;
McPhee, A ;
Carlin, JB .
PEDIATRICS, 2006, 117 (01) :75-83
[10]   Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: Effect modification by risk for chronic lung disease [J].
Doyle, LW ;
Halliday, HL ;
Ehrenkranz, RA ;
Davis, PG ;
Sinclair, JC .
PEDIATRICS, 2005, 115 (03) :655-661